Terms: = Brain cancer AND PAM50 AND Prognosis
3 results:
1. Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor.
Nacer DF; Liljedahl H; Karlsson A; Lindgren D; Staaf J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33971670
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of high metabolic activity in breast cancer: PET signature in breast cancer.
Kang S; Kim EH; Hwang JE; Shin JH; Jeong YS; Yim SY; Joo EW; Eun YG; Lee DJ; Sohn BH; Lee SH; Lim B; Lee JS
Biochem Biophys Res Commun; 2019 Mar; 511(1):185-191. PubMed ID: 30777332
[TBL] [Abstract] [Full Text] [Related]
